QSS
LJPC

Quantitative Systematic Strategies’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Quantitative Systematic Strategies’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-27,725
Closed -$261K – 800
2018
Q4 		$261K Buy
+27,725
New +$417K 0.06% 456

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Quantitative Systematic Strategies's LJPC Position: Q1 2019 in Review

Quantitative Systematic Strategies sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2019, closing a stake of 27,725 shares — an estimated $261K sold.

Quantitative Systematic Strategies first reported a position in LJPC in Q4 2018 and held it in 1 quarter. The position peaked at $261K in Q4 2018. 80 funds tracked by Wall St. Rank hold LJPC as of Q1 2019.

  • Quantitative Systematic Strategies reported no remaining La Jolla Pharmaceutical Company position as of Q1 2019 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 27,725 La Jolla Pharmaceutical Company shares in Q1 2019, an estimated $261K.
  • Quantitative Systematic Strategies first reported a position in La Jolla Pharmaceutical Company in Q4 2018 and held it in 1 quarter.
  • Quantitative Systematic Strategies's La Jolla Pharmaceutical Company position peaked at $261K in Q4 2018.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2019.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2019, filed 15 Apr 2019.